Cargando…

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective

Natural killer (NK) cells play an essential role in the fight against tumor development. Over the last years, the progress made in the NK-cell biology field and in deciphering how NK-cell function is regulated, is driving efforts to utilize NK-cell-based immunotherapy as a promising approach for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eguizabal, Cristina, Zenarruzabeitia, Olatz, Monge, Jorge, Santos, Silvia, Vesga, Miguel Angel, Maruri, Natalia, Arrieta, Arantza, Riñón, Marta, Tamayo-Orbegozo, Estibaliz, Amo, Laura, Larrucea, Susana, Borrego, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164009/ https://www.ncbi.nlm.nih.gov/pubmed/25309538 http://dx.doi.org/10.3389/fimmu.2014.00439

Ejemplares similares

Involvement of Platelet–Tumor Cell Interaction in Immune Evasion. Potential Role of Podocalyxin-Like Protein 1
por: Amo, Laura, et al.
Publicado: (2014)

Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2017)

Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2020)

Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site
por: Amo, Laura, et al.
Publicado: (2022)

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma
por: Orrantia, Ane, et al.
Publicado: (2021)

NK Cell-Based Immunotherapy in Renal Cell Carcinoma
por: Terrén, Iñigo, et al.
Publicado: (2020)

Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
por: Orrantia, Ane, et al.
Publicado: (2021)

IL-12/15/18-induced cell death and mitochondrial dynamics of human NK cells
por: Terrén, Iñigo, et al.
Publicado: (2023)

Metabolic changes of Interleukin-12/15/18-stimulated human NK cells
por: Terrén, Iñigo, et al.
Publicado: (2021)

Identification and Functional Analysis of Human CD56(neg) NK Cells by Flow Cytometry
por: Orrantia, Ane, et al.
Publicado: (2020)

Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
por: Terrén, Iñigo, et al.
Publicado: (2022)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors
por: Herrera, Lara, et al.
Publicado: (2017)

Immunotherapeutic Applications of NK Cells
por: Davis, Carter T., et al.
Publicado: (2015)

The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults
por: Zenarruzabeitia, Olatz, et al.
Publicado: (2016)

Differential expression of viral PAMP receptors mRNA in peripheral blood of patients with chronic hepatitis C infection
por: Atencia, Rafael, et al.
Publicado: (2007)

Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
por: Terrén, Iñigo, et al.
Publicado: (2018)

Analysis of the impact of handling and culture on the expansion and functionality of NK cells
por: Martin-Iglesias, Sara, et al.
Publicado: (2023)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

Human IgM(hi)CD300a(+) B Cells Are Circulating Marginal Zone Memory B Cells That Respond to Pneumococcal Polysaccharides and Their Frequency Is Decreased in People Living with HIV
por: Vitallé, Joana, et al.
Publicado: (2023)

CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
por: Vitallé, Joana, et al.
Publicado: (2019)

Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
por: Herrera, L., et al.
Publicado: (2019)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
por: Carreño, Leandro J, et al.
Publicado: (2016)

The Expression and Function of CD300 Molecules in the Main Players of Allergic Responses: Mast Cells, Basophils and Eosinophils
por: Vitallé, Joana, et al.
Publicado: (2020)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

In vivo expansion of a CD9(+) decidual-like NK cell subset following autologous hematopoietic stem cell transplantation
por: Orrantia, Ane, et al.
Publicado: (2022)

A NKp80-Based Identification Strategy Reveals that CD56(neg) NK Cells Are Not Completely Dysfunctional in Health and Disease
por: Orrantia, Ane, et al.
Publicado: (2020)

Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D
por: Gröschel, Carina, et al.
Publicado: (2017)

The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics
por: Mehra, Vedika, et al.
Publicado: (2023)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
por: Yamazaki, Takahiro, et al.
Publicado: (2021)

Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics
por: Market, Marisa, et al.
Publicado: (2022)

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
por: Brown, Bruce K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rceurnelkbmrot92qcj30p1435